In key news on Australian stocks, ResMed Inc. (NYSE:RMD) (AU:RMD) surged nearly 8% as of writing, driven by the company’s robust Q3 results for FY24. The company’s third-quarter performance reflected ...

Following Through on Healthcare Provider Conversations Remains a Challenge: While 66% of respondents say they would consult a healthcare provider for persistent sleep issues, only 23% have done so.

SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been ...

SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on ...

Instead of trying to predict market swings, I prefer focusing on businesses I would be comfortable holding through an entire cycle. The post 3 excellent ASX shares I'd happily hold through the next ...

Sydney: Sleep-breathing device maker ResMed plans to take global a doctor ‍education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, ⁠calling ...

ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from its major competitor. Despite a strong last quarter ...

The positions in the table below reflect the ResMed Ltd.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long ...